Supplementary material

Bjelakovic G, Nikolova D, Wetterslev J, Gluud C. Comment to: ‘Meta-analysis of long-term vitamin D supplementation on overall mortality’. PLOS ONE. 2014.

Bjelakovic G, Nikolova D, Wetterslev J, Gluud C. Comment to: ‘Meta-analysis of long-term vitamin D supplementation on overall mortality’. PLOS ONE. 2014. Figure 1. Intervention effect of vitamin D3 and vitamin D2 vs placebo or no intervention on mortality. Figure 2. Trial sequential analysis of 20 vitamin D3 trials with low risk of bias. The …

Bjelakovic G, Nikolova D, Wetterslev J, Gluud C. Comment to: ‘Meta-analysis of long-term vitamin D supplementation on overall mortality’. PLOS ONE. 2014. Read More »

Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database of Systematic Reviews. 2014, 1, s. CD007470.

Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database of Systematic Reviews. 2014, 1, s. CD007470. Figure w7 (Analysis 1.1): Funnel plot of comparison 1.1 Vitamin D versus placebo/no intervention. Outcome: 1.1 All-cause mortality in trials with a low …

Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database of Systematic Reviews. 2014, 1, s. CD007470. Read More »

Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal TP, Hemmingsen C, Wetterslev J. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. 11 nov 2013, 11, s. CD008143.

Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal TP, Hemmingsen C, Wetterslev J. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. 11 nov 2013, 11, s. CD008143. Figure web 7: Trial sequential analysis for the trials exclusively dealing with glycaemic control on all-cause …

Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal TP, Hemmingsen C, Wetterslev J. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. 11 nov 2013, 11, s. CD008143. Read More »

European Clinical Research Infrastructures Network (ECRIN) – transnational working groups (TWG) – 2008 reports

European Clinical Research Infrastructures Network (ECRIN) – transnational working groups (TWG) – 2008 reports: Deliverable 1 – Securing participant’s autonomy and interacting with ethics committees. View.Deliverable 2 – Clinical Research in Europe: interaction with ethics committees before, during and after a clinical trial. View.Deliverable 3 – Potential publications. View.Deliverable 4 – Clinical research in Europe: national differences …

European Clinical Research Infrastructures Network (ECRIN) – transnational working groups (TWG) – 2008 reports Read More »

Rambaldi A, Saconato HH, Christensen E, Thorlund K, Wetterslev J, Gluud C. Glucocorticosteroids for alcoholic hepatitis – a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther. 2008; 27(12): 1167-78.

Rambaldi A, Saconato HH, Christensen E, Thorlund K, Wetterslev J, Gluud C. Glucocorticosteroids for alcoholic hepatitis – a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther. 2008; 27(12): 1167-78. Figure S1 Figure S2 Figure S3

Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007; 297(8): 842-57.

Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007; 297(8): 842-57. References to excluded trials 405References to included trials 385